HAP Trading’s Regenxbio RGNX Stock Holding History

HAP Trading’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,376	Closed	-$533K	–	1357
2019 Q2	$533K	Buy	+10,376	New	+$518K	0.04%	325

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HAP Trading's RGNX Position: Q3 2019 in Review

HAP Trading sold out of Regenxbio (RGNX) in Q3 2019, closing a stake of 10,376 shares — an estimated $533K sold.

HAP Trading first reported a position in RGNX in Q2 2019 and held it in 1 quarter. The position peaked at $533K in Q2 2019. 168 funds tracked by Wall St. Rank hold RGNX as of Q3 2019.

HAP Trading reported no remaining Regenxbio position as of Q3 2019 after selling out during the quarter.
HAP Trading sold 10,376 Regenxbio shares in Q3 2019, an estimated $533K.
HAP Trading first reported a position in Regenxbio in Q2 2019 and held it in 1 quarter.
HAP Trading's Regenxbio position peaked at $533K in Q2 2019.
168 funds tracked by Wall St. Rank held Regenxbio as of Q3 2019.

Based on HAP Trading's 13F filing for Q3 2019, filed 12 Nov 2019.